
search
Search
Previous issuances
Since the inaugural benchmark issuance in 2006, IFFIm bonds have been issued in Japan, the UK, Australia and in the Eurobond market. IFFIm also has issued in the Islamic finance market.Our timeline charts all previous issuances.2024October…
Brazil announces support for global immunisation and IFFIm to save millions of world’s poorest children
Under President Lula's leadership, Brazil joins European nations in bid to use capital markets to raise funds for the GAVI Alliance London, 9 March 2006 - The President of Brazil, Luiz Inacio Lula da Silva, announced today that Brazil will…
IFFIm helps COVAX bring fair, global access to COVID-19 vaccines
With vaccine bonds, donors and private investors are tackling the toughest global health crisis in a century In the spring of 2020, as the novel coronavirus began to envelop the world, it was clear that a vaccine, available everywhere, would be…
Government of Brazil signs grant agreement for US$ 20 million in support to IFFIm
Becomes second BRICS donor to support accelerated funding for Gavi immunisation programmes in the world's poorest countries London – 11 October 2018 – The Government of Brazil formally approved today a grant of US$ 20 million to the International…
IFFIm raises more than US$ 2 billion to support life-saving immunisation programmes in poorest countries
The International Finance Facility for Immunisation satisfies strong demand for ethical investments and helps ensure children are vaccinated Press Releases Geneva, 19 May 2009 - The International Finance Facility for Immunisation (IFFIm) has…
'Vaccine bonds' offer Japanese savers an ethical investment
"Vaccine bonds" will offer Japanese investors a fixed rate of return plus an opportunity to see their money used to help immunise children in the world's poorest countries Tokyo, 16 January 2009 - "Vaccine bonds" which are expected go on sale in…
Paris presentation introduces a new supranational bond issuer: The International Finance Facility for Immunisation
Proceeds Will be Used to Scale Up GAVI Alliance, Boost Vaccine Use and Improve Health Systems to Save Lives of Millions of Poorest Children Paris, 12 October 2006 - The International Finance Facility for Immunisation (IFFIm), the World Bank, as…
First year results: IFFIm provides US$ 1 billion to prevent disease
Children’s rights campaigner Graça Machel and the GAVI Alliance celebrate the results of IFFIm support Cape Town, 28 November 2007 - Nearly US$ 1 billion is being injected into life-saving vaccines and health services in developing countries as a…
IFFIm takes next steps toward saving millions of lives
Directors Named, Treasury Manager Selected Geneva, 21 February 2006 - The International Finance Facility for Immunization (IFFIm), the new multinational fund that will leverage long-term commitments from rich governments to raise urgently…
Bond investors speed up access to life saving vaccines
Backed by six European nations, US$1 billion inaugural bond launch responds to yellow fever threat Geneva, May 31, 2007 - The GAVI Alliance announced today it will distribute almost US$1 billion in funds in 2007, raised by the International…
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.